2010 Sponsors
Take advantage of this unique opportunity to strengthen your company's brand and meet hundreds of potential new clients all interested in discovering how China's preclinical development industry may benefit their company. The audience will consist of small to medium-sized drug development companies and multinational pharmaceutical companies who are either looking to conduct preclinical studies in China, or who are already conducting preclinical studies in China.
For more information on the benefits of becoming a sponsor, please contact Jon E. Liong at jon.liong@lycheegroup.com or call +1-732-917-0664 to sign up.
2010 Sponsors
|
|
BRONZE Sponsors
 |
China Preclinical Management Services (CPMS) CPMS is a U.S. corporation (incorporated in Delaware), which was spun out of Cambridge Healthtech Associates (CHA) to assist Western and Chinese bio-pharmaceutical companies to leverage US FDA/OECD GLP compliant safety facilities in China. As such, the mission of CPMS is to support the bio-pharmaceutical industry’s efforts to improve new drug development economics by fully leveraging high quality, economical preclinical development resources in China. CPMS offers services which help sponsors (typically small to mid-size US and/or China based drug development companies) plan and implement programs that fully exploit the potential advantages of working with Chinese GLP CROs. This includes enabling sponsors to meet their obligation to maintain full US FDA quality and compliance expectations (i.e. fully GLP compliant studies). CPMS also partners with Chinese CROs in their efforts to develop their offerings to meet all expectations, and achieve maximum benefit for Western sponsors. www.chinapreclin.com  |
 |
Frontier BioSciences, Inc. Frontier BioSciences, Inc. is preclinical CRO in Chengdu and Kunming, China, providing a full range of services, from proof-of-concept to general toxicology studies, designed for supporting submissions to China SFDA and U.S. FDA. Our in-house capabilities include safety and efficacy studies, PK/TK, Animal Models, General Toxicology, Developmental & Reproductive Toxicology, Safety Pharmacology, and Genetic Toxicology, supported by bioanalytical, clinical pathology, and histopathology services. The state-of-the art toxicology facilities encompass a total of 300,000 sq. ft. and are equipped with the latest advanced technology, and are operated by highly-trained and experienced staff with international CRO experience. www.frontierbsi.com |
 |
Instem Instem is a leading provider of pre-clinical IT solutions to the Life Sciences. Its customer base consists of pharmaceutical, chemical and contract research organizations, including government and privately funded programs worldwide. Instem’s prominent position in the Life Sciences was established in the area of drug safety assessment. Instem currently leads this global market with its Provantis® Tox/Path software solution commanding a 60% share. |
Exhibitors
 |
Charles River Preclinical Services Shanghai Charles River has increased its global reach with a preclinical facility in China that provides a high level of customer care in close proximity to its sponsors. Charles River Preclinical Services Shanghai partners with customers to provide comprehensive quality solutions at a competitive price and successfully execute a wide range of toxicology and laboratory services in all species from discovery to IND submission. Charles River Preclinical Services Shanghai is an AAALAC accredited and GLP compliant certified facility that meets all global regulatory standards and has a scientific team that is experienced with a wide range of compounds and therapeutic areas. www.criver.com. |